ASND insider transaction filings

Ascendis Pharma A/S — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-09. Screen ASND transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 3 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Bodenhoff Mads — SVP & PAO11 leg · 3,000 sh · $810,5702
BIENAIME JEAN JACQUES — Director12 legs · 2,000 sh · $492,654
HOLTUG LARS — Director11 leg · 236 sh · $62,335

Recent Form 4 filings — Ascendis Pharma A/S

FiledFormInsiderReported transactionsSource
2026-09-094Bodenhoff Mads — SVP & PAOOption exercise (M): 3,000 @ $110 · Sale (S): 3,000 @ $270.19 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-09-034HOLTUG LARS — DirectorSale (S): 236 @ $264.13EDGAR
2026-08-184BIENAIME JEAN JACQUES — DirectorPurchase (P): 1,100 @ $245.85 · Purchase (P): 900 @ $246.91EDGAR
2026-06-024SMITH SCOTT THOMAS — EVP & Chief Financial OfficerPurchase (P): 100 @ $219EDGAR
2026-06-014SMITH SCOTT THOMAS — EVP & Chief Financial OfficerPurchase (P): 250 @ $223.32EDGAR
2026-06-014BIENAIME JEAN JACQUES — DirectorPurchase (P): 200 @ $223.76 · Purchase (P): 200 @ $222.30 · Purchase (P): 100 @ $223.50EDGAR
2026-05-274BIENAIME JEAN JACQUES — DirectorPurchase (P): 200 @ $236.24 · Purchase (P): 200 @ $239.37EDGAR
2026-05-124JENSEN FLEMMING STEEN — See RemarksSale (S): 19,460 @ $238.49EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ASND returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →